Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Ion Torrent Systems Inc.

Division of Thermo Fisher Scientific Inc.
www.iontorrent.com

Latest From Ion Torrent Systems Inc.

China Dips Its Toes in Disruptive IVD Tech

The number of Chinese IVD companies exhibiting at the 2015 American Association for Clinical Chemistry Annual Meeting (AACC) & Clinical Lab Expo (CLE) was slightly down from last year, but the breadth of diagnostic products and innovations from China appears to be on the up. Hrishi Poola and Jon Chen discuss the moves China is making to become a generator of disruptive technologies and reports on the new products and the players emerging from this market

Medical Device China

RainDance Launches ThunderBolts Next-Gen Sequencing Cancer Panel

RainDance Technologies announced the official launch of the ThunderBolts cancer panel this week at the American Association for Cancer Research annual meeting in San Diego, where researchers demonstrated the system’s ability to genetically profile various types of tumors for as little as $100 per sample.

Medical Device Platform Technologies

Qiagen Moves Into Next-Gen Sequencing

Qiagen has acquired privately held Intelligent Bio-Systems, a developer of next-generation sequencing (NGS) instruments aimed at the clinical research market. IBS’ technology, along with a newly expanded collaboration with bioinformatics provider SAP, is the cornerstone of a new NGS initiative at Qiagen.

Medical Device Strategy

Personalized Medicine In 2010: Welcome To The Establishment

Evidence of progress for molecular diagnostics and instrumentation, the mainstays of the personalized medicine toolkit, was considerable in 2010. Much of the activity centered on sequencing, although its general utility in clinical diagnostics has not yet been demonstrated and whether measurements of gene expression can form the basis for a plethora of molecular tests also remains an open question. In abbreviated form, we list some of the important dealmaking activities and trends of the year.
Platform Technologies Research and Development Strategies
See All

Company Information

  • Industry
  • Biotechnology
    • Drug Discovery Tools
      • Bioinformatics
      • Genomics-Proteomics
    • Nanotechnology, Chips, etc.
  • In Vitro Diagnostics
  • Research, Analytical Equipment & Supplies
  • Therapeutic Areas
  • Non-Specific
  • Alias(es)
  • Ownership
  • Private
  • Headquarters
  • Worldwide
    • North America
      • USA
  • Parent & Subsidiaries
  • Thermo Fisher Scientific Inc.
  • Senior Management
  • Jonathan M Rothberg, PhD, Chmn. & CEO
    Gregg Fergus, Pres. & COO
    Maneesh Jain, PhD, VP, Mktg. & Bus. Dev.
    Jamie Kole, VP, Fin. & Admin.
  • Contact Info
  • Ion Torrent Systems Inc.
    Phone: (203) 458-8552
    246 Goose Ln., Ste. 100
    Guilford, CT 06437
    USA
Advertisement
Advertisement
UsernamePublicRestriction

Register